Monitoring progress with national and subnational health goals by integrating verbal autopsy and medically certified cause of death data.


Journal

BMJ global health
ISSN: 2059-7908
Titre abrégé: BMJ Glob Health
Pays: England
ID NLM: 101685275

Informations de publication

Date de publication:
05 2021
Historique:
received: 15 02 2021
revised: 12 04 2021
accepted: 19 04 2021
entrez: 1 6 2021
pubmed: 2 6 2021
medline: 25 6 2021
Statut: ppublish

Résumé

The measurement of progress towards many Sustainable Development Goals (SDG) and other health goals requires accurate and timely all-cause and cause of death (COD) data. However, existing guidance to countries to calculate these indicators is inadequate for populations with incomplete death registration and poor-quality COD data. We introduce a replicable method to estimate national and subnational cause-specific mortality rates (and hence many such indicators) where death registration is incomplete by integrating data from Medical Certificates of Cause of Death (MCCOD) for hospital deaths with routine verbal autopsy (VA) for community deaths. The integration method calculates population-level cause-specific mortality fractions (CSMFs) from the CSMFs of MCCODs and VAs weighted by estimated deaths in hospitals and the community. Estimated deaths are calculated by applying the empirical completeness method to incomplete death registration/reporting. The resultant cause-specific mortality rates are used to estimate SDG Indicator 23: mortality between ages 30 and 70 years from cardiovascular diseases, cancers, chronic respiratory diseases and diabetes. We demonstrate the method using nationally representative data in Myanmar, comprising over 42 000 VAs and 7600 MCCODs. In Myanmar in 2019, 89% of deaths were estimated to occur in the community. VAs comprised an estimated 70% of community deaths. Both the proportion of deaths in the community and CSMFs for the four causes increased with older age. We estimated that the probability of dying from any of the four causes between 30 and 70 years was 0.265 for men and 0.216 for women. This indicator is 50% higher if based on CSMFs from the integration of data sources than on MCCOD data from hospitals. This integration method facilitates country authorities to use their data to monitor progress with national and subnational health goals, rather than rely on estimates made by external organisations. The method is particularly relevant given the increasing application of routine VA in country Civil Registration and Vital Statistics systems.

Identifiants

pubmed: 34059494
pii: bmjgh-2021-005387
doi: 10.1136/bmjgh-2021-005387
pmc: PMC8169488
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

BMC Med. 2020 Mar 9;18(1):60
pubmed: 32146903
BMC Med. 2020 Mar 9;18(1):55
pubmed: 32146899
Lancet. 2020 Sep 26;396(10255):918-934
pubmed: 32891217
Lancet. 2018 Nov 10;392(10159):2091-2138
pubmed: 30496107
Int J Epidemiol. 2019 Jun 1;48(3):966-977
pubmed: 30915430
Popul Health Metr. 2010 May 18;8:14
pubmed: 20482761
BMC Med. 2020 Mar 9;18(1):65
pubmed: 32146904
PLoS One. 2018 May 30;13(5):e0197047
pubmed: 29847573
Bull World Health Organ. 2014 Nov 1;92(11):807-16
pubmed: 25378742
BMC Med. 2019 Feb 8;17(1):29
pubmed: 30732593
BMC Med. 2020 Mar 9;18(1):58
pubmed: 32146906
BMJ Open. 2019 May 16;9(5):e027689
pubmed: 31101699
BMC Med. 2020 Mar 9;18(1):74
pubmed: 32146900
PLoS Med. 2019 Nov 19;16(11):e1002975
pubmed: 31743352
Lancet. 2020 Oct 17;396(10258):1160-1203
pubmed: 33069325
BMC Med. 2015 Dec 16;13:302
pubmed: 26670275
BMC Med. 2014 Jan 09;12:5
pubmed: 24405531
BMC Med. 2020 Mar 9;18(1):61
pubmed: 32146907
BMC Public Health. 2019 Jan 24;19(1):110
pubmed: 30678685
Lancet. 2015 Oct 3;386(10001):1395-1406
pubmed: 25971218
Lancet. 2020 Oct 17;396(10258):1204-1222
pubmed: 33069326

Auteurs

Tim Adair (T)

Melbourne School of Population and Global Health, The University of Melbourne, Carlton, Victoria, Australia timothy.adair@unimelb.edu.au.

Sonja Firth (S)

Melbourne School of Population and Global Health, The University of Melbourne, Carlton, Victoria, Australia.

Tint Pa Pa Phyo (TPP)

Central Statistical Organization, Nay Pyi Taw, Myanmar.

Khin Sandar Bo (KS)

Melbourne School of Population and Global Health, The University of Melbourne, Carlton, Victoria, Australia.

Alan D Lopez (AD)

Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH